nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—asthma—chronic obstructive pulmonary disease	0.433	1	CtDrD
Ipratropium bromide—Methylscopolamine bromide—Tiotropium—chronic obstructive pulmonary disease	0.237	1	CrCrCtD
Ipratropium bromide—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.0555	0.227	CbGbCtD
Ipratropium bromide—CHRM5—Tiotropium—chronic obstructive pulmonary disease	0.0401	0.164	CbGbCtD
Ipratropium bromide—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.0314	0.128	CbGbCtD
Ipratropium bromide—CHRM3—Tiotropium—chronic obstructive pulmonary disease	0.0256	0.105	CbGbCtD
Ipratropium bromide—CHRM1—Tiotropium—chronic obstructive pulmonary disease	0.0223	0.0911	CbGbCtD
Ipratropium bromide—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.0206	0.084	CbGbCtD
Ipratropium bromide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.00841	0.0344	CbGbCtD
Ipratropium bromide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.00841	0.0344	CbGbCtD
Ipratropium bromide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0075	0.0306	CbGbCtD
Ipratropium bromide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00706	0.0288	CbGbCtD
Ipratropium bromide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00477	0.0195	CbGbCtD
Ipratropium bromide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00455	0.0186	CbGbCtD
Ipratropium bromide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00405	0.0166	CbGbCtD
Ipratropium bromide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00238	0.00971	CbGbCtD
Ipratropium bromide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00225	0.00917	CbGbCtD
Ipratropium bromide—Dexmethylphenidate—SLC6A4—chronic obstructive pulmonary disease	0.00034	0.379	CrCbGaD
Ipratropium bromide—Methylphenidate—SLC6A4—chronic obstructive pulmonary disease	0.00034	0.379	CrCbGaD
Ipratropium bromide—Atropine—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.242	CrCbGaD
Ipratropium bromide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	8.55e-05	0.00109	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	8.53e-05	0.00109	CcSEcCtD
Ipratropium bromide—Nervousness—Formoterol—chronic obstructive pulmonary disease	8.48e-05	0.00108	CcSEcCtD
Ipratropium bromide—Nervousness—Arformoterol—chronic obstructive pulmonary disease	8.48e-05	0.00108	CcSEcCtD
Ipratropium bromide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	8.47e-05	0.00108	CcSEcCtD
Ipratropium bromide—Back pain—Arformoterol—chronic obstructive pulmonary disease	8.44e-05	0.00108	CcSEcCtD
Ipratropium bromide—Back pain—Formoterol—chronic obstructive pulmonary disease	8.44e-05	0.00108	CcSEcCtD
Ipratropium bromide—Nausea—Roflumilast—chronic obstructive pulmonary disease	8.34e-05	0.00106	CcSEcCtD
Ipratropium bromide—Ulcer—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.00106	CcSEcCtD
Ipratropium bromide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	8.24e-05	0.00105	CcSEcCtD
Ipratropium bromide—Tremor—Formoterol—chronic obstructive pulmonary disease	8.18e-05	0.00104	CcSEcCtD
Ipratropium bromide—Tremor—Arformoterol—chronic obstructive pulmonary disease	8.18e-05	0.00104	CcSEcCtD
Ipratropium bromide—Flatulence—Salbutamol—chronic obstructive pulmonary disease	8.12e-05	0.00104	CcSEcCtD
Ipratropium bromide—Tension—Salbutamol—chronic obstructive pulmonary disease	8.09e-05	0.00103	CcSEcCtD
Ipratropium bromide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	8.07e-05	0.00103	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	8.04e-05	0.00103	CcSEcCtD
Ipratropium bromide—Tremor—Montelukast—chronic obstructive pulmonary disease	8.01e-05	0.00102	CcSEcCtD
Ipratropium bromide—Nervousness—Salbutamol—chronic obstructive pulmonary disease	8e-05	0.00102	CcSEcCtD
Ipratropium bromide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	7.98e-05	0.00102	CcSEcCtD
Ipratropium bromide—Angioedema—Formoterol—chronic obstructive pulmonary disease	7.98e-05	0.00102	CcSEcCtD
Ipratropium bromide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	7.98e-05	0.00102	CcSEcCtD
Ipratropium bromide—Back pain—Salbutamol—chronic obstructive pulmonary disease	7.97e-05	0.00102	CcSEcCtD
Ipratropium bromide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	7.93e-05	0.00101	CcSEcCtD
Ipratropium bromide—Angioedema—Montelukast—chronic obstructive pulmonary disease	7.81e-05	0.000997	CcSEcCtD
Ipratropium bromide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	7.77e-05	0.000992	CcSEcCtD
Ipratropium bromide—Tremor—Salbutamol—chronic obstructive pulmonary disease	7.72e-05	0.000986	CcSEcCtD
Ipratropium bromide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	7.71e-05	0.000985	CcSEcCtD
Ipratropium bromide—Palpitations—Formoterol—chronic obstructive pulmonary disease	7.71e-05	0.000985	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	7.65e-05	0.000977	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	7.62e-05	0.000973	CcSEcCtD
Ipratropium bromide—Cough—Arformoterol—chronic obstructive pulmonary disease	7.62e-05	0.000972	CcSEcCtD
Ipratropium bromide—Cough—Formoterol—chronic obstructive pulmonary disease	7.62e-05	0.000972	CcSEcCtD
Ipratropium bromide—Palpitations—Montelukast—chronic obstructive pulmonary disease	7.56e-05	0.000965	CcSEcCtD
Ipratropium bromide—Constipation—Tiotropium—chronic obstructive pulmonary disease	7.55e-05	0.000964	CcSEcCtD
Ipratropium bromide—Hypertension—Formoterol—chronic obstructive pulmonary disease	7.54e-05	0.000962	CcSEcCtD
Ipratropium bromide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	7.54e-05	0.000962	CcSEcCtD
Ipratropium bromide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	7.53e-05	0.000961	CcSEcCtD
Ipratropium bromide—Cough—Montelukast—chronic obstructive pulmonary disease	7.46e-05	0.000952	CcSEcCtD
Ipratropium bromide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	7.44e-05	0.000949	CcSEcCtD
Ipratropium bromide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	7.43e-05	0.000949	CcSEcCtD
Ipratropium bromide—Chest pain—Formoterol—chronic obstructive pulmonary disease	7.43e-05	0.000949	CcSEcCtD
Ipratropium bromide—Myalgia—Formoterol—chronic obstructive pulmonary disease	7.43e-05	0.000949	CcSEcCtD
Ipratropium bromide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	7.43e-05	0.000949	CcSEcCtD
Ipratropium bromide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	7.4e-05	0.000945	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	7.38e-05	0.000942	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	7.38e-05	0.000942	CcSEcCtD
Ipratropium bromide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	7.28e-05	0.00093	CcSEcCtD
Ipratropium bromide—Myalgia—Montelukast—chronic obstructive pulmonary disease	7.28e-05	0.000929	CcSEcCtD
Ipratropium bromide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	7.27e-05	0.000928	CcSEcCtD
Ipratropium bromide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	7.27e-05	0.000928	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	7.23e-05	0.000923	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	7.22e-05	0.000921	CcSEcCtD
Ipratropium bromide—Cough—Salbutamol—chronic obstructive pulmonary disease	7.19e-05	0.000918	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	7.12e-05	0.000909	CcSEcCtD
Ipratropium bromide—Oedema—Formoterol—chronic obstructive pulmonary disease	7.12e-05	0.000909	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	7.12e-05	0.000909	CcSEcCtD
Ipratropium bromide—Oedema—Arformoterol—chronic obstructive pulmonary disease	7.12e-05	0.000909	CcSEcCtD
Ipratropium bromide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	7.12e-05	0.000908	CcSEcCtD
Ipratropium bromide—Infection—Formoterol—chronic obstructive pulmonary disease	7.08e-05	0.000903	CcSEcCtD
Ipratropium bromide—Infection—Arformoterol—chronic obstructive pulmonary disease	7.08e-05	0.000903	CcSEcCtD
Ipratropium bromide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	7.02e-05	0.000896	CcSEcCtD
Ipratropium bromide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	7.02e-05	0.000896	CcSEcCtD
Ipratropium bromide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	7.01e-05	0.000895	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	6.99e-05	0.000892	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	6.99e-05	0.000892	CcSEcCtD
Ipratropium bromide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	6.98e-05	0.000891	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	6.98e-05	0.000891	CcSEcCtD
Ipratropium bromide—Oedema—Montelukast—chronic obstructive pulmonary disease	6.98e-05	0.000891	CcSEcCtD
Ipratropium bromide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	6.95e-05	0.000888	CcSEcCtD
Ipratropium bromide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	6.95e-05	0.000888	CcSEcCtD
Ipratropium bromide—Infection—Montelukast—chronic obstructive pulmonary disease	6.93e-05	0.000885	CcSEcCtD
Ipratropium bromide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	6.92e-05	0.000883	CcSEcCtD
Ipratropium bromide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	6.92e-05	0.000883	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	6.9e-05	0.00088	CcSEcCtD
Ipratropium bromide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	6.86e-05	0.000876	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	6.84e-05	0.000874	CcSEcCtD
Ipratropium bromide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	6.78e-05	0.000865	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	6.73e-05	0.000859	CcSEcCtD
Ipratropium bromide—Oedema—Salbutamol—chronic obstructive pulmonary disease	6.73e-05	0.000859	CcSEcCtD
Ipratropium bromide—Infection—Salbutamol—chronic obstructive pulmonary disease	6.68e-05	0.000853	CcSEcCtD
Ipratropium bromide—Hypotension—Formoterol—chronic obstructive pulmonary disease	6.66e-05	0.00085	CcSEcCtD
Ipratropium bromide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	6.66e-05	0.00085	CcSEcCtD
Ipratropium bromide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	6.62e-05	0.000845	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	6.6e-05	0.000842	CcSEcCtD
Ipratropium bromide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	6.56e-05	0.000838	CcSEcCtD
Ipratropium bromide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	6.53e-05	0.000834	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	6.5e-05	0.00083	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	6.5e-05	0.00083	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	6.49e-05	0.000829	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	6.49e-05	0.000829	CcSEcCtD
Ipratropium bromide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	6.44e-05	0.000823	CcSEcCtD
Ipratropium bromide—Insomnia—Formoterol—chronic obstructive pulmonary disease	6.44e-05	0.000823	CcSEcCtD
Ipratropium bromide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	6.4e-05	0.000818	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	6.36e-05	0.000812	CcSEcCtD
Ipratropium bromide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	6.35e-05	0.000811	CcSEcCtD
Ipratropium bromide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	6.35e-05	0.000811	CcSEcCtD
Ipratropium bromide—Somnolence—Formoterol—chronic obstructive pulmonary disease	6.33e-05	0.000808	CcSEcCtD
Ipratropium bromide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	6.33e-05	0.000808	CcSEcCtD
Ipratropium bromide—Insomnia—Montelukast—chronic obstructive pulmonary disease	6.31e-05	0.000806	CcSEcCtD
Ipratropium bromide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	6.29e-05	0.000802	CcSEcCtD
Ipratropium bromide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	6.27e-05	0.000801	CcSEcCtD
Ipratropium bromide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	6.27e-05	0.000801	CcSEcCtD
Ipratropium bromide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	6.27e-05	0.0008	CcSEcCtD
Ipratropium bromide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	6.25e-05	0.000797	CcSEcCtD
Ipratropium bromide—Somnolence—Montelukast—chronic obstructive pulmonary disease	6.2e-05	0.000792	CcSEcCtD
Ipratropium bromide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.19e-05	0.00079	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	6.15e-05	0.000785	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	6.15e-05	0.000785	CcSEcCtD
Ipratropium bromide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	6.14e-05	0.000784	CcSEcCtD
Ipratropium bromide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	6.14e-05	0.000784	CcSEcCtD
Ipratropium bromide—Fatigue—Formoterol—chronic obstructive pulmonary disease	6.14e-05	0.000784	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.13e-05	0.000782	CcSEcCtD
Ipratropium bromide—Pain—Arformoterol—chronic obstructive pulmonary disease	6.09e-05	0.000778	CcSEcCtD
Ipratropium bromide—Pain—Formoterol—chronic obstructive pulmonary disease	6.09e-05	0.000778	CcSEcCtD
Ipratropium bromide—Constipation—Formoterol—chronic obstructive pulmonary disease	6.09e-05	0.000778	CcSEcCtD
Ipratropium bromide—Constipation—Arformoterol—chronic obstructive pulmonary disease	6.09e-05	0.000778	CcSEcCtD
Ipratropium bromide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	6.08e-05	0.000777	CcSEcCtD
Ipratropium bromide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	6.04e-05	0.000771	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	6.02e-05	0.000769	CcSEcCtD
Ipratropium bromide—Fatigue—Montelukast—chronic obstructive pulmonary disease	6.02e-05	0.000768	CcSEcCtD
Ipratropium bromide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	6e-05	0.000766	CcSEcCtD
Ipratropium bromide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	5.98e-05	0.000763	CcSEcCtD
Ipratropium bromide—Pain—Montelukast—chronic obstructive pulmonary disease	5.97e-05	0.000762	CcSEcCtD
Ipratropium bromide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	5.95e-05	0.00076	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	5.93e-05	0.000757	CcSEcCtD
Ipratropium bromide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	5.92e-05	0.000756	CcSEcCtD
Ipratropium bromide—Rash—Aminophylline—chronic obstructive pulmonary disease	5.9e-05	0.000753	CcSEcCtD
Ipratropium bromide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	5.9e-05	0.000753	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	5.88e-05	0.000751	CcSEcCtD
Ipratropium bromide—Headache—Aminophylline—chronic obstructive pulmonary disease	5.86e-05	0.000749	CcSEcCtD
Ipratropium bromide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	5.84e-05	0.000745	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	5.83e-05	0.000744	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	5.83e-05	0.000744	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	5.81e-05	0.000741	CcSEcCtD
Ipratropium bromide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	5.8e-05	0.00074	CcSEcCtD
Ipratropium bromide—Pain—Salbutamol—chronic obstructive pulmonary disease	5.75e-05	0.000734	CcSEcCtD
Ipratropium bromide—Constipation—Salbutamol—chronic obstructive pulmonary disease	5.75e-05	0.000734	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	5.71e-05	0.000728	CcSEcCtD
Ipratropium bromide—Urticaria—Formoterol—chronic obstructive pulmonary disease	5.66e-05	0.000722	CcSEcCtD
Ipratropium bromide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	5.66e-05	0.000722	CcSEcCtD
Ipratropium bromide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	5.63e-05	0.000719	CcSEcCtD
Ipratropium bromide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	5.63e-05	0.000719	CcSEcCtD
Ipratropium bromide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	5.61e-05	0.000716	CcSEcCtD
Ipratropium bromide—Rash—Tiotropium—chronic obstructive pulmonary disease	5.57e-05	0.000711	CcSEcCtD
Ipratropium bromide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	5.56e-05	0.00071	CcSEcCtD
Ipratropium bromide—Nausea—Aminophylline—chronic obstructive pulmonary disease	5.56e-05	0.00071	CcSEcCtD
Ipratropium bromide—Urticaria—Montelukast—chronic obstructive pulmonary disease	5.54e-05	0.000708	CcSEcCtD
Ipratropium bromide—Headache—Tiotropium—chronic obstructive pulmonary disease	5.53e-05	0.000706	CcSEcCtD
Ipratropium bromide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	5.52e-05	0.000704	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	5.5e-05	0.000702	CcSEcCtD
Ipratropium bromide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	5.46e-05	0.000697	CcSEcCtD
Ipratropium bromide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	5.43e-05	0.000693	CcSEcCtD
Ipratropium bromide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	5.34e-05	0.000682	CcSEcCtD
Ipratropium bromide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	5.32e-05	0.000679	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.25e-05	0.00067	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.25e-05	0.00067	CcSEcCtD
Ipratropium bromide—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.24e-05	0.000669	CcSEcCtD
Ipratropium bromide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	5.23e-05	0.000668	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.14e-05	0.000656	CcSEcCtD
Ipratropium bromide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	5.11e-05	0.000652	CcSEcCtD
Ipratropium bromide—Asthenia—Formoterol—chronic obstructive pulmonary disease	5.11e-05	0.000652	CcSEcCtD
Ipratropium bromide—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.04e-05	0.000643	CcSEcCtD
Ipratropium bromide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.04e-05	0.000643	CcSEcCtD
Ipratropium bromide—Asthenia—Montelukast—chronic obstructive pulmonary disease	5.01e-05	0.000639	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	4.96e-05	0.000633	CcSEcCtD
Ipratropium bromide—Pruritus—Montelukast—chronic obstructive pulmonary disease	4.94e-05	0.00063	CcSEcCtD
Ipratropium bromide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	4.87e-05	0.000622	CcSEcCtD
Ipratropium bromide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	4.87e-05	0.000622	CcSEcCtD
Ipratropium bromide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	4.83e-05	0.000616	CcSEcCtD
Ipratropium bromide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	4.77e-05	0.000609	CcSEcCtD
Ipratropium bromide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	4.76e-05	0.000608	CcSEcCtD
Ipratropium bromide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	4.71e-05	0.000601	CcSEcCtD
Ipratropium bromide—Dizziness—Formoterol—chronic obstructive pulmonary disease	4.71e-05	0.000601	CcSEcCtD
Ipratropium bromide—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.61e-05	0.000589	CcSEcCtD
Ipratropium bromide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	4.6e-05	0.000588	CcSEcCtD
Ipratropium bromide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	4.53e-05	0.000578	CcSEcCtD
Ipratropium bromide—Vomiting—Formoterol—chronic obstructive pulmonary disease	4.53e-05	0.000578	CcSEcCtD
Ipratropium bromide—Rash—Formoterol—chronic obstructive pulmonary disease	4.49e-05	0.000573	CcSEcCtD
Ipratropium bromide—Rash—Arformoterol—chronic obstructive pulmonary disease	4.49e-05	0.000573	CcSEcCtD
Ipratropium bromide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.49e-05	0.000573	CcSEcCtD
Ipratropium bromide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.49e-05	0.000573	CcSEcCtD
Ipratropium bromide—Headache—Arformoterol—chronic obstructive pulmonary disease	4.46e-05	0.00057	CcSEcCtD
Ipratropium bromide—Headache—Formoterol—chronic obstructive pulmonary disease	4.46e-05	0.00057	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	4.46e-05	0.000569	CcSEcCtD
Ipratropium bromide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.45e-05	0.000568	CcSEcCtD
Ipratropium bromide—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.44e-05	0.000566	CcSEcCtD
Ipratropium bromide—Rash—Montelukast—chronic obstructive pulmonary disease	4.4e-05	0.000562	CcSEcCtD
Ipratropium bromide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.4e-05	0.000561	CcSEcCtD
Ipratropium bromide—Headache—Montelukast—chronic obstructive pulmonary disease	4.37e-05	0.000558	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	4.32e-05	0.000551	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	4.31e-05	0.00055	CcSEcCtD
Ipratropium bromide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	4.28e-05	0.000546	CcSEcCtD
Ipratropium bromide—Rash—Salbutamol—chronic obstructive pulmonary disease	4.24e-05	0.000541	CcSEcCtD
Ipratropium bromide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.24e-05	0.000541	CcSEcCtD
Ipratropium bromide—Nausea—Formoterol—chronic obstructive pulmonary disease	4.23e-05	0.00054	CcSEcCtD
Ipratropium bromide—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.23e-05	0.00054	CcSEcCtD
Ipratropium bromide—Headache—Salbutamol—chronic obstructive pulmonary disease	4.21e-05	0.000538	CcSEcCtD
Ipratropium bromide—Nausea—Montelukast—chronic obstructive pulmonary disease	4.14e-05	0.000529	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	4.08e-05	0.000521	CcSEcCtD
Ipratropium bromide—Nausea—Salbutamol—chronic obstructive pulmonary disease	4e-05	0.00051	CcSEcCtD
Ipratropium bromide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	3.97e-05	0.000506	CcSEcCtD
Ipratropium bromide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	3.95e-05	0.000504	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	3.86e-05	0.000493	CcSEcCtD
Ipratropium bromide—Oedema—Prednisolone—chronic obstructive pulmonary disease	3.86e-05	0.000493	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	3.77e-05	0.000481	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	3.73e-05	0.000476	CcSEcCtD
Ipratropium bromide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	3.69e-05	0.000471	CcSEcCtD
Ipratropium bromide—Flushing—Prednisone—chronic obstructive pulmonary disease	3.66e-05	0.000468	CcSEcCtD
Ipratropium bromide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	3.56e-05	0.000455	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.49e-05	0.000445	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	3.46e-05	0.000442	CcSEcCtD
Ipratropium bromide—Pain—Prednisolone—chronic obstructive pulmonary disease	3.3e-05	0.000421	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	3.24e-05	0.000413	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisone—chronic obstructive pulmonary disease	3.14e-05	0.000401	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.06e-05	0.000391	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisone—chronic obstructive pulmonary disease	2.97e-05	0.000379	CcSEcCtD
Ipratropium bromide—Myalgia—Prednisone—chronic obstructive pulmonary disease	2.92e-05	0.000373	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	2.9e-05	0.000371	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	2.84e-05	0.000363	CcSEcCtD
Ipratropium bromide—Oedema—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000358	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000358	CcSEcCtD
Ipratropium bromide—Infection—Prednisone—chronic obstructive pulmonary disease	2.79e-05	0.000356	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	2.75e-05	0.000351	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	2.74e-05	0.000349	CcSEcCtD
Ipratropium bromide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	2.72e-05	0.000348	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	2.71e-05	0.000346	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.55e-05	0.000326	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.55e-05	0.000326	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.54e-05	0.000324	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	2.52e-05	0.000321	CcSEcCtD
Ipratropium bromide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.47e-05	0.000315	CcSEcCtD
Ipratropium bromide—Rash—Prednisolone—chronic obstructive pulmonary disease	2.43e-05	0.000311	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.43e-05	0.00031	CcSEcCtD
Ipratropium bromide—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.42e-05	0.000309	CcSEcCtD
Ipratropium bromide—Headache—Prednisolone—chronic obstructive pulmonary disease	2.42e-05	0.000309	CcSEcCtD
Ipratropium bromide—Constipation—Prednisone—chronic obstructive pulmonary disease	2.4e-05	0.000306	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.29e-05	0.000293	CcSEcCtD
Ipratropium bromide—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.29e-05	0.000293	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000284	CcSEcCtD
Ipratropium bromide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.22e-05	0.000283	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.07e-05	0.000264	CcSEcCtD
Ipratropium bromide—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.01e-05	0.000257	CcSEcCtD
Ipratropium bromide—Pruritus—Prednisone—chronic obstructive pulmonary disease	1.98e-05	0.000253	CcSEcCtD
Ipratropium bromide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	1.92e-05	0.000245	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.85e-05	0.000237	CcSEcCtD
Ipratropium bromide—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.78e-05	0.000228	CcSEcCtD
Ipratropium bromide—Rash—Prednisone—chronic obstructive pulmonary disease	1.77e-05	0.000226	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.77e-05	0.000225	CcSEcCtD
Ipratropium bromide—Headache—Prednisone—chronic obstructive pulmonary disease	1.76e-05	0.000224	CcSEcCtD
Ipratropium bromide—Nausea—Prednisone—chronic obstructive pulmonary disease	1.67e-05	0.000213	CcSEcCtD
Ipratropium bromide—CHRM3—Metabolism—APIP—chronic obstructive pulmonary disease	1.35e-05	0.00203	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.34e-05	0.00203	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	1.31e-05	0.00198	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	1.31e-05	0.00197	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	1.29e-05	0.00194	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.28e-05	0.00193	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.24e-05	0.00188	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.24e-05	0.00187	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.23e-05	0.00186	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.00186	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.23e-05	0.00186	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	1.23e-05	0.00185	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	1.22e-05	0.00184	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.21e-05	0.00183	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.2e-05	0.00181	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	1.2e-05	0.00181	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.00173	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.13e-05	0.00171	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.13e-05	0.00171	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.13e-05	0.00171	CbGpPWpGaD
Ipratropium bromide—CHRM5—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.13e-05	0.0017	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	1.12e-05	0.00169	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.11e-05	0.00168	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.11e-05	0.00167	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.1e-05	0.00166	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	1.09e-05	0.00165	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	1.08e-05	0.00164	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	1.07e-05	0.00162	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.06e-05	0.0016	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.06e-05	0.0016	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.05e-05	0.00159	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.05e-05	0.00159	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.05e-05	0.00159	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.04e-05	0.00158	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.04e-05	0.00157	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.03e-05	0.00156	CbGpPWpGaD
Ipratropium bromide—SLC22A4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.02e-05	0.00154	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	1.01e-05	0.00152	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.00151	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	9.91e-06	0.0015	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.86e-06	0.00149	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.7e-06	0.00147	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.67e-06	0.00146	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.59e-06	0.00145	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.58e-06	0.00145	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.56e-06	0.00144	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.47e-06	0.00143	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.45e-06	0.00143	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.42e-06	0.00142	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.33e-06	0.00141	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9e-06	0.00136	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.91e-06	0.00135	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.88e-06	0.00134	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	8.67e-06	0.00131	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.51e-06	0.00129	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.51e-06	0.00129	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.49e-06	0.00128	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.45e-06	0.00128	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.42e-06	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.4e-06	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	8.4e-06	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	8.39e-06	0.00127	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.34e-06	0.00126	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.06e-06	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.05e-06	0.00122	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	8.05e-06	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	7.93e-06	0.0012	CbGpPWpGaD
Ipratropium bromide—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	7.91e-06	0.0012	CbGpPWpGaD
Ipratropium bromide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	7.83e-06	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.73e-06	0.00117	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.71e-06	0.00116	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.66e-06	0.00116	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.63e-06	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.59e-06	0.00115	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.51e-06	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.48e-06	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.45e-06	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.44e-06	0.00112	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.4e-06	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.39e-06	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.38e-06	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.37e-06	0.00111	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.29e-06	0.0011	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	7.19e-06	0.00109	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.9e-06	0.00104	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	6.89e-06	0.00104	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.8e-06	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.78e-06	0.00102	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.54e-06	0.000988	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.49e-06	0.00098	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.48e-06	0.00098	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	6.46e-06	0.000976	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.45e-06	0.000974	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.16e-06	0.00093	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.99e-06	0.000906	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.98e-06	0.000903	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.93e-06	0.000896	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.92e-06	0.000894	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.92e-06	0.000894	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.9e-06	0.000891	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.8e-06	0.000877	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.67e-06	0.000856	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.65e-06	0.000853	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.59e-06	0.000845	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.39e-06	0.000814	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.34e-06	0.000807	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.33e-06	0.000805	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.32e-06	0.000804	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.27e-06	0.000797	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.26e-06	0.000795	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	5.24e-06	0.000792	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	5.18e-06	0.000783	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.85e-06	0.000733	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.83e-06	0.000731	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.82e-06	0.000728	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	4.8e-06	0.000725	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.79e-06	0.000723	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.77e-06	0.000721	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.76e-06	0.000719	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.74e-06	0.000717	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.74e-06	0.000716	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.71e-06	0.000712	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	4.68e-06	0.000707	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.57e-06	0.00069	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.56e-06	0.00069	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.55e-06	0.000688	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.55e-06	0.000688	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.55e-06	0.000687	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.53e-06	0.000685	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.51e-06	0.000681	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.51e-06	0.000681	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.41e-06	0.000666	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.33e-06	0.000655	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.32e-06	0.000653	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.28e-06	0.000647	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	4.27e-06	0.000646	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.18e-06	0.000631	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.16e-06	0.000629	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.12e-06	0.000623	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.07e-06	0.000615	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.94e-06	0.000595	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.79e-06	0.000573	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.78e-06	0.000571	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.74e-06	0.000566	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.66e-06	0.000554	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.64e-06	0.000549	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.48e-06	0.000527	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.39e-06	0.000512	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.34e-06	0.000505	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.33e-06	0.000503	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.33e-06	0.000503	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.31e-06	0.000499	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.3e-06	0.000498	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.28e-06	0.000496	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.24e-06	0.000489	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.18e-06	0.000481	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.15e-06	0.000476	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.1e-06	0.000469	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.09e-06	0.000468	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.06e-06	0.000463	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.02e-06	0.000456	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.96e-06	0.000447	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.87e-06	0.000433	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.86e-06	0.000432	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.86e-06	0.000432	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.83e-06	0.000428	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.83e-06	0.000427	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.8e-06	0.000423	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.58e-06	0.00039	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.57e-06	0.000389	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.56e-06	0.000387	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.55e-06	0.000386	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.55e-06	0.000386	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.55e-06	0.000385	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.53e-06	0.000382	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.43e-06	0.000367	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.35e-06	0.000356	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.34e-06	0.000354	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.34e-06	0.000353	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.33e-06	0.000352	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.32e-06	0.000351	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.32e-06	0.000351	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.31e-06	0.000349	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.3e-06	0.000347	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.24e-06	0.000338	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.23e-06	0.000337	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.22e-06	0.000335	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.21e-06	0.000334	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.08e-06	0.000315	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.08e-06	0.000314	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.06e-06	0.000311	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.97e-06	0.000297	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.96e-06	0.000297	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	1.94e-06	0.000294	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.94e-06	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.87e-06	0.000282	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.86e-06	0.000281	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.85e-06	0.00028	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.83e-06	0.000277	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.8e-06	0.000273	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.78e-06	0.000269	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.71e-06	0.000259	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.71e-06	0.000258	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.71e-06	0.000258	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.69e-06	0.000255	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.67e-06	0.000252	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.63e-06	0.000247	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.63e-06	0.000246	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.61e-06	0.000244	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.6e-06	0.000241	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.56e-06	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.56e-06	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.54e-06	0.000233	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.54e-06	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.47e-06	0.000221	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.44e-06	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.38e-06	0.000209	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.38e-06	0.000208	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.37e-06	0.000206	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.32e-06	0.000199	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.31e-06	0.000198	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.3e-06	0.000196	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-06	0.000194	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.27e-06	0.000191	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.25e-06	0.000189	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.25e-06	0.000189	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.24e-06	0.000187	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.21e-06	0.000182	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-06	0.000178	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-06	0.000176	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.12e-06	0.00017	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.12e-06	0.000169	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-06	0.000169	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-06	0.000168	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.11e-06	0.000168	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.1e-06	0.000167	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.03e-06	0.000156	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.03e-06	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.02e-06	0.000154	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.01e-06	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.01e-06	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.98e-07	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.49e-07	0.000128	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.47e-07	0.000128	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.38e-07	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.77e-07	0.000117	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.75e-07	0.000117	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.67e-07	0.000116	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.6e-07	0.000115	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.27e-07	0.00011	CbGpPWpGaD
